Literature DB >> 7322454

Reinforcing and other behavioral effects of nicotine.

J Dougherty, D Miller, G Todd, H B Kostenbauder.   

Abstract

Published findings of intravenous nicotine self-injection indicate that the reinforcing properties of nicotine are weak when the drug is made available according to continuous reinforcement (CRF) or fixed-ratio (FR) schedules. CRF self-injection rates are generally only 2-3 times saline control levels and self-injection frequency is largely insensitive to changes in unit dose. In contrast, drugs of the psychomotor stimulant, opiate, and sedative-hypnotic classes, with similar pharmacokinetic parameters, maintain much higher self-injection rates and show systematic changes in rate with unit dose variations. Recent studies using interval and second-order schedules of nicotine presentation have been more successful in maintaining higher rates of self-administration behavior. Systematic dose-response functions have also been found under these conditions. Food-deprivation, species and strain differences, circadian rhythms, and duration of exposure to the drug also appear to be important variables in determining self-injection rate. Finally, the rapid development of tolerance to the effects of nicotine may account for changes in the pattern of self-administration within daily sessions and the differential sensitivity of those patterns to nicotine pretreatment.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7322454     DOI: 10.1016/0149-7634(81)90019-1

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  15 in total

1.  Euphoriant effects of nicotine in smokers.

Authors:  C S Pomerleau; O F Pomerleau
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement.

Authors:  Nadia Chaudhri; Anthony R Caggiula; Eric C Donny; Matthew I Palmatier; Xiu Liu; Alan F Sved
Journal:  Psychopharmacology (Berl)       Date:  2005-10-21       Impact factor: 4.530

Review 3.  Nicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research.

Authors:  Jack E Henningfield; Tracy T Smith; Bethea A Kleykamp; Reginald V Fant; Eric C Donny
Journal:  Psychopharmacology (Berl)       Date:  2016-10-21       Impact factor: 4.530

4.  Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats.

Authors:  R A Wise; A Murray; M A Bozarth
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Examining the reinforcement-enhancement effects of phencyclidine and its interactions with nicotine on lever-pressing for a visual stimulus.

Authors:  Natashia Swalve; Scott T Barrett; Rick A Bevins; Ming Li
Journal:  Behav Brain Res       Date:  2015-05-27       Impact factor: 3.332

6.  Robust escalation of nicotine intake with extended access to nicotine self-administration and intermittent periods of abstinence.

Authors:  Ami Cohen; George F Koob; Olivier George
Journal:  Neuropsychopharmacology       Date:  2012-05-02       Impact factor: 7.853

7.  Isolation of a nicotine binding site from rat brain by affinity chromatography.

Authors:  L G Abood; W Latham; S Grassi
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

8.  Nicotine self-administration in rats.

Authors:  B M Cox; A Goldstein; W T Nelson
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

9.  Pre- and post-nicotine circadian activity rhythms can be differentiated by a paired environmental cue.

Authors:  Andrea G Gillman; Ann E K Kosobud; William Timberlake
Journal:  Physiol Behav       Date:  2007-09-26

10.  Neonatal ethanol exposure produces a hyperalgesia that extends into adolescence, and is associated with increased analgesic and rewarding properties of nicotine in rats.

Authors:  Dennis T Rogers; Susan Barron; John M Littleton
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.